Mitochondrial ROS formation in the pathogenesis of diabetic cardiomyopathy

N Kaludercic, F Di Lisa - Frontiers in Cardiovascular Medicine, 2020 - frontiersin.org
Diabetic cardiomyopathy is a result of diabetes-induced changes in the structure and
function of the heart. Hyperglycemia affects multiple pathways in the diabetic heart, but …

Diabetic cardiovascular disease induced by oxidative stress

Y Kayama, U Raaz, A Jagger, M Adam… - International journal of …, 2015 - mdpi.com
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among
patients with diabetes mellitus (DM). DM can lead to multiple cardiovascular complications …

Cardiac oxidative stress in diabetes: mechanisms and therapeutic potential

A Faria, SJ Persaud - Pharmacology & therapeutics, 2017 - Elsevier
Macrovascular complications of diabetes, including diabetic cardiovascular disease (CVD),
occur through a number of hyperglycaemia-induced mechanisms that include generation of …

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol

PAL Pacher, A Nivorozhkin, C Szabó - Pharmacological reviews, 2006 - ASPET
The prototypical xanthine oxidase (XO) inhibitor allopurinol, has been the cornerstone of the
clinical management of gout and conditions associated with hyperuricemia for several …

[HTML][HTML] Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme

MG Battelli, A Bolognesi, L Polito - … Acta (BBA)-Molecular Basis of Disease, 2014 - Elsevier
The enzyme xanthine oxidoreductase (XOR) catalyses the last step of purine degradation in
the highest uricotelic primates as a rate-limiting enzyme in nucleic acid catabolism. Although …

Impact of oxypurinol in patients with symptomatic heart failure: results of the OPT-CHF study

JM Hare, B Mangal, J Brown, C Fisher… - Journal of the American …, 2008 - jacc.org
Objectives: This study evaluated whether a xanthine oxidase (XO) inhibitor, oxypurinol,
produces clinical benefits in patients with New York Heart Association functional class III to …

Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress

J George, AD Struthers - Vascular health and risk management, 2009 - Taylor & Francis
Oxidative stress plays an important role in the progression of vascular endothelial
dysfunction. The two major systems generating vascular oxidative stress are the NADPH …

Uric acid expression in carotid atherosclerotic plaque and serum uric acid are associated with cerebrovascular events

V Nardi, F Franchi, M Prasad, EM Fatica… - …, 2022 - Am Heart Assoc
Background: Uric acid (UA) concentration within carotid plaque and its association with
cerebrovascular events have not been detected or quantified. Systemically, serum UA is a …

Gout, allopurinol use, and heart failure outcomes

G Thanassoulis, JM Brophy, H Richard… - Archives of Internal …, 2010 - jamanetwork.com
Background Hyperuricemia is associated with reduced survival among patients with heart
failure (HF), but the effect of gout on HF outcomes is unknown. A recent randomized trial …

Xanthine oxidoreductase is a regulator of adipogenesis and PPARγ activity

KJ Cheung, I Tzameli, P Pissios, I Rovira, O Gavrilova… - Cell metabolism, 2007 - cell.com
In an effort to identify novel candidate regulators of adipogenesis, gene profiling of
differentiating 3T3-L1 preadipocytes was analyzed using a novel algorithm. We report here …